




Searching News Database: lung transplant
HSMN NewsFeed - 21 Jul 2021
FDA Grants Breakthrough Designation to Synapse Biomedical's TransAeris(R) System
FDA Grants Breakthrough Designation to Synapse Biomedical's TransAeris(R) System
HSMN NewsFeed - 20 Jun 2019
CollPlant Announces Corporate Name Change to CollPlant Biotechnologies to Better Reflect Its Business
CollPlant Announces Corporate Name Change to CollPlant Biotechnologies to Better Reflect Its Business
HSMN NewsFeed - 8 May 2018
TFF Pharmaceuticals Announces Appointment of Glenn Mattes as New Chief Executive Officer
TFF Pharmaceuticals Announces Appointment of Glenn Mattes as New Chief Executive Officer
HSMN NewsFeed - 3 Apr 2018
Biopharm Startup TFF Pharmaceuticals Raises $14M for Breakthrough Dry Powder Inhalation Platform
Biopharm Startup TFF Pharmaceuticals Raises $14M for Breakthrough Dry Powder Inhalation Platform
HSMN NewsFeed - 1 Sep 2016
Kamada and Kedrion Seek FDA Approval of Human Rabies Immunoglobulin as a Post-Exposure Treatment
Kamada and Kedrion Seek FDA Approval of Human Rabies Immunoglobulin as a Post-Exposure Treatment
HSMN NewsFeed - 26 May 2016
TransMedics, Inc. Announces Closing of $51.2 Million Growth Financing to Transform Organ Transplant Therapy
TransMedics, Inc. Announces Closing of $51.2 Million Growth Financing to Transform Organ Transplant Therapy
HSMN NewsFeed - 11 Mar 2016
HeartStitch, Inc. Appoints Renowned Cardiac Surgeon to Its Clinical Advisory Board
HeartStitch, Inc. Appoints Renowned Cardiac Surgeon to Its Clinical Advisory Board
HSMN NewsFeed - 25 Feb 2014
InterMune Reports Phase 3 ASCEND Trial Results of Pirfenidone in Idiopathic Pulmonary Fibrosis (IPF)
InterMune Reports Phase 3 ASCEND Trial Results of Pirfenidone in Idiopathic Pulmonary Fibrosis (IPF)
HSMN NewsFeed - 12 Dec 2013
Advanced Cell Technology Appoints Eddy Anglade M.D. Executive Vice President of Clinical Development
Advanced Cell Technology Appoints Eddy Anglade M.D. Executive Vice President of Clinical Development
HSMN NewsFeed - 12 Nov 2013
1,200th Worldwide Implant of the SynCardia Total Artificial Heart Occurs in Indiana
1,200th Worldwide Implant of the SynCardia Total Artificial Heart Occurs in Indiana
HSMN NewsFeed - 23 Sep 2013
Bayer receives approval for Adempas(R) as first drug to treat rare heart and lung disease
Bayer receives approval for Adempas(R) as first drug to treat rare heart and lung disease
HSMN NewsFeed - 9 May 2013
Sunshine Heart, Inc. Announces First Patient Implanted in C-Pulse System European Post-Market Study
Sunshine Heart, Inc. Announces First Patient Implanted in C-Pulse System European Post-Market Study
HSMN NewsFeed - 26 Feb 2013
Cytori Appoints Dr. Steven Kesten as Executive Vice President and Chief Medical Officer
Cytori Appoints Dr. Steven Kesten as Executive Vice President and Chief Medical Officer
HSMN NewsFeed - 27 Nov 2012
TransMedics, Inc. Secures $36 Million Round of Financing Led by Abrams Capital Management
TransMedics, Inc. Secures $36 Million Round of Financing Led by Abrams Capital Management
HSMN NewsFeed - 26 Oct 2012
NICE Approves Pharmaxis' Bronchitol(R) As An Important New Treatment Option For Cystic Fibrosis Patients
NICE Approves Pharmaxis' Bronchitol(R) As An Important New Treatment Option For Cystic Fibrosis Patients
HSMN NewsFeed - 5 Sep 2012
CircuLite(R) Receives CE Marking Approval for SYNERGY(R) Circulatory Support System
CircuLite(R) Receives CE Marking Approval for SYNERGY(R) Circulatory Support System
HSMN NewsFeed - 27 Apr 2011
Deep Breeze Introduces Breeze@home(TM) -- A New Telemonitoring Device to Improve COPD Assessment
Deep Breeze Introduces Breeze@home(TM) -- A New Telemonitoring Device to Improve COPD Assessment
HSMN NewsFeed - 20 Sep 2010
Aeris Therapeutics Announces CE Mark Approval for the AeriSeal(R) Emphysematous Lung Sealant System
Aeris Therapeutics Announces CE Mark Approval for the AeriSeal(R) Emphysematous Lung Sealant System
HSMN NewsFeed - 8 Sep 2010
XDx Appoints New Vice President of Corporate Development and Legal Affairs
XDx Appoints New Vice President of Corporate Development and Legal Affairs
HSMN NewsFeed - 25 Jun 2010
Olympus to Acquire Spiration, Inc., a U.S. Pulmonary Device Company, as a Consolidated Subsidiary
Olympus to Acquire Spiration, Inc., a U.S. Pulmonary Device Company, as a Consolidated Subsidiary
HSMN NewsFeed - 3 Aug 2009
CMS Approves New Technology Add-On Payment for Spiration(R) IBV Valve System
CMS Approves New Technology Add-On Payment for Spiration(R) IBV Valve System
HSMN NewsFeed - 26 May 2009
FDA Approves ADCIRCA(TM) (Tadalafil) Tablets for the Treatment of Pulmonary Arterial Hypertension
FDA Approves ADCIRCA(TM) (Tadalafil) Tablets for the Treatment of Pulmonary Arterial Hypertension
HSMN NewsFeed - 5 May 2009
Titan Medical Inc. Announces the Appointment of Dr. W. Douglas Boyd as Principal Investigator
Titan Medical Inc. Announces the Appointment of Dr. W. Douglas Boyd as Principal Investigator
HSMN NewsFeed - 21 Feb 2009
Nebraska Heart Institute First in the Nation to Implant Acorn(TM) Heart Failure Device Minimally Invasively
Nebraska Heart Institute First in the Nation to Implant Acorn(TM) Heart Failure Device Minimally Invasively
HSMN NewsFeed - 4 Dec 2008
Broncus Technologies Secures $38 Million in Funding Round Led by Ares Life Sciences
Broncus Technologies Secures $38 Million in Funding Round Led by Ares Life Sciences
HSMN NewsFeed - 8 Oct 2008
Spiration, Inc. Announces European Launch of Minimally Invasive Pulmonary Device
Spiration, Inc. Announces European Launch of Minimally Invasive Pulmonary Device
HSMN NewsFeed - 9 Apr 2008
World's First 4-lb Discharge Driver For Powering CardioWest Artificial Heart Unveiled at ISHLT in Boston
World's First 4-lb Discharge Driver For Powering CardioWest Artificial Heart Unveiled at ISHLT in Boston
HSMN NewsFeed - 22 Oct 2007
Deep Breeze Ltd. Launches Unique Non-Invasive, Radiation-Free Pulmonary Imaging System in the U.S.
Deep Breeze Ltd. Launches Unique Non-Invasive, Radiation-Free Pulmonary Imaging System in the U.S.
HSMN NewsFeed - 10 Aug 2007
MAP Pharmaceuticals Promotes Stephen B. Shrewsbury to Position of Chief Medical Officer
MAP Pharmaceuticals Promotes Stephen B. Shrewsbury to Position of Chief Medical Officer
HSMN NewsFeed - 31 May 2007
Abiomed Appoints Eric A. Rose, M.D., a Leader in Circulatory Care, to Its Board of Directors
Abiomed Appoints Eric A. Rose, M.D., a Leader in Circulatory Care, to Its Board of Directors
HSMN NewsFeed - 2 Feb 2007
FDA Approves New Dosing Recommendations for RAPAMUNE in High Immunologic Risk Renal Transplant Patients
FDA Approves New Dosing Recommendations for RAPAMUNE in High Immunologic Risk Renal Transplant Patients
HSMN NewsFeed - 31 Oct 2006
Gene Expression Test From XDx Now Indicated for Earlier Use and Prediction of Acute Cellular Rejection
Gene Expression Test From XDx Now Indicated for Earlier Use and Prediction of Acute Cellular Rejection
HSMN NewsFeed - 27 Jun 2006
FDA Approves Abiomed's IDE for IMPELLA 5.0 Minimally Invasive Cardiac Support Systems
FDA Approves Abiomed's IDE for IMPELLA 5.0 Minimally Invasive Cardiac Support Systems
Additional items found! 54

Members Archive contains
54 additional stories matching:
lung transplant
(Password required)
lung transplant
(Password required)